Acute Myelogenous Leukemia
New acute myelogenous leukemia study results reported from University of California
Published in Genetics and Environmental Law Weekly, November 14th, 2009
"We performed a retrospective analysis on 45 patients aged 2 1 to 73 years (median 5 1 years) with de novo AML who underwent APBSCT stratified by age, complete remission status, and cytogenetic risk. The 5-year disease-free survival (DFS) for all patients was 33.9% (95% confidence interval [CI], 20.1%-53.7%) and overall survival (OS) was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
More Articles from Genetics and Environmental Law Weekly
- Genetics & Genomics
Leaders in Healthcare to Examine Impact of Comparative Effectiveness Research on Personalized Medicine - University of Chicago Medical Center
Protein critical for insulin secretion may be contributor to diabetes - Acute Lymphoblastic Leukemia
Studies from D. Hoelzer and co-researchers yield new data on acute lymphoblastic leukemia - Affymetrix, Inc.
Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET(TM) Plus Panel - Alzheimer Disease
New findings reported from Federal University describe advances in Alzheimer disease - Alzheimer Disease
Study results from University of Texas in the area of Alzheimer disease published - More from this issue of Genetics and Environmental Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
